S. Kozin

Molecular Biology · 2004–2013

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 32 citations into it; #6,416 of 17,773 by trust here, #2,832 by citations
• Cancer Research — 20 citations into it; #1,274 of 1,780 by trust here, #758 by citations
• Oncology — 18 citations into it; #615 of 1,698 by trust here, #475 by citations

Whom S. Kozin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Rakesh K. Jain

Who trusts S. Kozin overall

1. Rakesh K. Jain
2. J. Joyce
3. Dai Fukumura

Papers from S. Kozin's perspective

Ordered by how strongly the researchers S. Kozin trusts endorse each paper. Same corpus, a different order for every researcher.

1. Pathology: Cancer cells compress intratumour vessels (Nature)
2. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
3. Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
4. Clinical translation of angiogenesis inhibitors (Nature Reviews. Cancer)
5. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
6. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. (Cancer Cell)
7. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis (Science)
8. Transport of molecules across tumor vasculature (Cancer Metastasis Review)
9. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics (Science)
10. Cell mechanics: integrating cell responses to mechanical stimuli. (Annual Review of Biomedical Engineering)

Their papers

• Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (2004) — 2,071 citations
• Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (2004) — 1,208 citations
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. (2004) — 1,344 citations
• Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels (2013) — 943 citations
• Differentiating the pathologies of cerebral malaria by postmortem parasite counts (2004) — 685 citations